Dr. Megan Greene is a pharmacist who is specialized in Pediatrics in Aurora, Colorado. Patients can reach her at 13123 E 16th Ave # B100, Aurora or contact her on 720-777-3054. Active license number of Dr. Megan Greene is PHA.0021858 for Pediatrics in Colorado. Dr. Megan Greene is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists that ensures the safe and effective use of medications for all children from neonates through adolescents.
Complete Profile:
Dr. Megan Greene speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Megan Greene
Specialization:
Pediatrics
Credentials:
PHARMD, BCPPS
Gender:
Female
Location:
13123 E 16th Ave # B100, Aurora, Colorado, 80045-7106
Phone:
720-777-3054
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Megan Greene are as mentioned below.
NPI Number:
1861000515
NPI Enumeration Date:
20 Jul, 2020
NPI Last Update On:
20 Jul, 2020
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Megan Greene are as mentioned below.
Specialization
License Number
State
Status
Pediatrics
PHA.0021858
Colorado
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2044 N High St, Denver, Colorado
Zip:
80205-5556
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Megan Greene at 13123 E 16th Ave # B100, Aurora, Colorado or can call on phone at 720-777-3054.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.